Literature DB >> 18983211

Exenatide and pancreatitis: an update.

Steve C Bain, Jeffrey W Stephens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18983211     DOI： 10.1517/14740330802432003

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN： 1474-0338            Impact factor:   4.250


× No keyword cloud information.
  15 in total

1.  Collateral damage: the conundrum of drug safety.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2009-10       Impact factor: 10.122

2.  The phospholipase A(2) inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice.

Authors:  D Y Hui; M J Cope; E D Labonté; H-T Chang; J Shao; E Goka; A Abousalham; D Charmot; J Buysse
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

3.  Novel treatments for type 2 diabetes.

Authors:  Jason Seewoodhary; Stephen C Bain
Journal:  Br J Gen Pract       Date:  2011-01       Impact factor: 5.386

4.  Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export.

Authors:  Fawzi Alogaili; Sivaprakasam Chinnarasu; Anja Jaeschke; Evangelia G Kranias; David Y Hui
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

5.  Role and development of GLP-1 receptor agonists in the management of diabetes.

Authors:  Chee W Chia; Josephine M Egan
Journal:  Diabetes Metab Syndr Obes       Date:  2009-05-15       Impact factor: 3.168

6.  Liraglutide in the treatment of type 2 diabetes mellitus: clinical utility and patient perspectives.

Authors:  Mahamood Edavalath; Jeffrey W Stephens
Journal:  Patient Prefer Adherence       Date:  2010-03-24       Impact factor: 2.711

7.  Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.

Authors:  G Schernthaner; A H Barnett; D J Betteridge; R Carmena; A Ceriello; B Charbonnel; M Hanefeld; R Lehmann; M T Malecki; R Nesto; V Pirags; A Scheen; J Seufert; A Sjohölm; A Tsatsoulis; R DeFronzo
Journal:  Diabetologia       Date:  2010-03-31       Impact factor: 10.122

8.  Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas.

Authors:  J S Nachnani; D G Bulchandani; A Nookala; B Herndon; A Molteni; P Pandya; R Taylor; T Quinn; L Weide; L M Alba
Journal:  Diabetologia       Date:  2009-09-13       Impact factor: 10.122

Review 9.  What are the risks and the benefits of current and emerging weight-loss medications?

Authors:  Jamie R Robinson; Kevin D Niswender
Journal:  Curr Diab Rep       Date:  2009-10       Impact factor: 4.810

10.  Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studies.

Authors:  Samuel S Engel; Elizabeth Round; Gregory T Golm; Keith D Kaufman; Barry J Goldstein
Journal:  Diabetes Ther       Date:  2013-05-23       Impact factor: 2.945
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.